Canada

The BC PharmaCare program approves additional drugs, expands the scope

From Canadian Press staff

Published May 2, 2022, 9:19 p.m.

Smaller font Reduce the font size of the article

-Ah

Larger font Increase the font size of the article

A +

The Ministry of Health says thousands of eligible British Colombians are benefiting from expanded coverage for drugs that make it easier or more effective to treat their conditions.

A statement from the Ministry of Health said BC PharmaCare was introducing new or expanded coverage for a number of drugs from the end of last year.

The drugs treat conditions including ulcerative colitis and Crohn’s disease, very low blood sugar, migraines, low white blood cell counts, multiple sclerosis and heart failure.

Read more: BC offers mentors’ rights counselors who are detained by accident

The ministry says the new treatment, covered for colitis or Crohn’s disease, could be given to the patient instead of requiring a visit to a clinic, while a nasal spray is now available to treat low blood sugar or hypoglycaemia, eliminating regular injections of thousands. this condition.

Popular stories

  • A new eye scanning app can examine people for Alzheimer’s, ADHD: researchers

  • Elon Musk outlines big plans to transform Twitter. Here’s what we know so far

The story continues under the ad

The ministry estimates that at least 10,000 migraine patients will benefit from adding another drug to the official list of drugs, and the same number of patients with a specific type of heart failure will qualify for a drug that drastically reduces hospitalizations and deaths.

PharmaCare’s scope has also been expanded to include what the ministry says is a long-acting, highly effective birth control drug that is implanted in a patient’s upper arm as an alternative, a cheap option for birth control pills or intrauterine devices.

5:40 Web series sheds light on care and mental health Web series sheds light on care and mental health

© 2022 The Canadian Press